Evidence map›Paper›PMID 39203860›Full record

ArticleNutrients2024

Nutrient Status and Intakes of Adults with Phenylketonuria.

Eva Venegas, Simone Langeveld, Kirsten Ahring, Rosa Benitez, An Desloovere, Elena Dios, Eva Gómez, Alvaro Hermida, Cyril Marsaux, Patrick Verloo and 1 more

Abstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eva VenegasEndocrinology and Nutrition Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Simone LangeveldDanone Research & Innovation, 3584 CT Utrecht, The Netherlands.ORCID 0000-0001-7604-3013
Kirsten AhringDepartment of Phenylketonuria, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
Rosa BenitezEndocrinology and Nutrition Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
An DesloovereDepartment of Pediatric Neurology, Center for Inherited Metabolic Disorders, University Hospital Ghent, European Reference Network for Hereditary Metabolic Disorders (MetabERN), 9000 Ghent, Belgium.
Elena DiosEndocrinology and Nutrition Department, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Eva GómezUnit for Diagnosis and Treatment of Congenital Metabolic Disorders, University Clinical Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), European Reference Network for Hereditary Metabolic Disorders (MetabERN), 15706 Santiago de Compostela, Spain.
Alvaro HermidaUnit for Diagnosis and Treatment of Congenital Metabolic Disorders, University Clinical Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), European Reference Network for Hereditary Metabolic Disorders (MetabERN), 15706 Santiago de Compostela, Spain.ORCID 0000-0003-3757-262X
Cyril MarsauxDanone Research & Innovation, 3584 CT Utrecht, The Netherlands.ORCID 0000-0002-4725-6359
Patrick VerlooDepartment of Pediatric Neurology, Center for Inherited Metabolic Disorders, University Hospital Ghent, European Reference Network for Hereditary Metabolic Disorders (MetabERN), 9000 Ghent, Belgium.ORCID 0000-0003-2077-0275
Maria-Luz CouceUnit for Diagnosis and Treatment of Congenital Metabolic Disorders, University Clinical Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), European Reference Network for Hereditary Metabolic Disorders (MetabERN), 15706 Santiago de Compostela, Spain.ORCID 0000-0003-4861-9905

Funding

Danone Research & Innovation N/A
6 · The paper itself

Abstract

A phenylalanine-restricted diet, supplemented with protein substitutes (PSs), remains the cornerstone of phenylketonuria (PKU) management. However, adherence is challenging in adulthood, and data on the nutritional status of early and continuously treated adults with PKU (ETAwPKU) are scarce. A total of 34 ETAwPKU (16 females; mean ± SD, age: 28 ± 9 years, phenylalanine concentration: 847 ± 285 µmol/L) and 34 age- and sex-matched control subjects were compared regarding their blood nutrient status, self-reported dietary intake, and cognitive wellbeing. Though diet adherence varied, all ETAwPKU were taking a PS. No significant differences were found for blood DHA, calcium, ferritin, transferrin, and zinc concentrations. However, selenium and ubiquinone concentrations were 16% and 29% lower in ETAwPKU, respectively (

Indexed as

Nutritional StatusPhenylalaninePhenylketonuriasAdultAmino AcidsCase-Control StudiesCognitionDietary SupplementsFemaleHumansMaleMicronutrientsVitaminsYoung AdultAmino AcidsMicronutrientsPhenylalanineVitaminsamino acidcognitive wellbeingmicronutrientnutritional statusphenylalanine hydroxylase deficiency

Identifiers

PMID39203860
PMCPMC11357144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.